The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab
Author:
Funder
Swedish Cancer Foundation
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference21 articles.
1. Phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group;Vermorken;Ann. Oncol.,2000
2. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a single-institutional phase II study;Kang;Gynecol. Oncol.,2009
3. phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinoma;Sorensen;Gynecol. Oncol.,2001
4. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat. Med.,1995
5. Vascular endothelial growth factor as a target for anticancer therapy;Ferrara;Oncologist,2004
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deep Learning Can Predict Bevacizumab Therapeutic Effect and Microsatellite Instability Directly from Histology in Epithelial Ovarian Cancer;Laboratory Investigation;2023-11
2. Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?;Biomedicines;2022-08-29
3. Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer;International Journal of Molecular Sciences;2021-12-20
4. Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine;Cancer Chemotherapy and Pharmacology;2020-04-11
5. Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer;Future Oncology;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3